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Thyroid hormones are the iodized derivatives of the amino
acid tyrosine and are synthesized by the thyroid gland.
Thyroxine (T4) and triiodothyronine (T3) regulate the
processes of general metabolism (oxidative phosphorylation),
growth, development and specific gene expression
(Oppenheimer & Schwartz, 1987; Samuels, 1988). About
90 % of the thyroid production is T4 while 10 % is T3. It is
thought that T4 has little, if any, biological activity, and it is
considered as a prohormone, which becomes activated upon
conversion into T3 in peripheral tissues. About 80 % of the
daily T3 production is generated via this process while the
remaining 20 % is directly secreted from the thyroid
(Hennemann, 1987).
To respond to thyroid hormone signals, cells have to contain
specific thyroid hormone receptors (nuclear proteins) and
thyroid hormone response elements (TRE) (specific DNA
sequences upstream of regulated genes) (Brent et al. 1989).
Thyroid hormone exerts its actions at a cellular level by
binding to specific thyroid hormone receptor (TR) and
binding of TR to TRE, in order to stimulate or inhibit the rate
of transcription of specific genes (Franklyn & Gammage,
1996). Up to now, two major classes of thyroid hormone
nuclear receptors have been described: thyroid hormone
receptor-a (TRa) and thyroid hormone receptor-b (TRb)
(Franklyn & Gammage, 1996; Nagaya et al. 1996). Several
isoforms (a1, a2, a3, b1 and b2) are created by alternative splicing
of TRa and TRb gene (Nagaya et al. 1996) and they display
differences in terms of their tissue distribution and functional
properties (Franklyn & Gammage, 1996). It has been shown
that TRa1, TRa2 and TRb1 are expressed in the myocardium,
and that TRa1 and TRb1 bind the ligand (thyroid hormone),
while TRa2 is non-ligand binding variant which may exert a
‘dominant negative’ influence on the action of a1 and b1
thyroid hormone receptor proteins (Brent et al. 1991;
Franklyn & Gammage, 1996).
Thyroid hormones have strong effects on the heart and
circulation. It is considered that thyroid hormones perform
direct and indirect actions on the heart. Thus, direct thyroid
hormone actions on the heart involve regulation of
transcription of a number of functionally relevant genes in
the myocardium (nuclear mechanism). These include the
myosin heavy chain contractile proteins (Ojamaa & Klein,
1993; Dubus et al. 1993), Na+,K+-ATPase (Liu et al. 1993;
Huang et al. 1994), Ca2+-ATPase and phospholamban
(Kimura et al. 1994), which modulate the activity of calcium
translocator (Klein & Ojamaa, 1996). But some effects, like
the thyroid hormone effects on calcium uptake by the
myocyte, are mediated by direct action on the plasma
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membrane (extranuclear mechanisms) (Gotzsche, 1994;
Franklyn & Gammage, 1996). Further studies in the heart
showed that thyroid hormones up-regulated the
development of b-adrenergic receptors (Pracyk & Slotkin,
1992) and in this way had an indirect effect on the heart,
mediated by possible altered sensitivity to catecholamine
action (Klein & Ojamaa, 1996).
To perform most of their biological actions, thyroid
hormones have to be translocated through the cell
membrane and reach a cell nucleus of the target cells. It was
shown that the transport of thyroid hormones through the
cell membrane is a carrier-mediated process (Hennemann et
al. 1987; Samson et al. 1996). Further studies showed that
the membrane transport of thyroid hormone is a stereo-
specific, facilitated or active process in many tissues and cell
types (Samson et al. 1996). However, the molecular
mechanisms of thyroid hormone transport into target cells
are not quite clear and they are of great interest.
In this study we have investigated the dynamics and kinetics
of 125I-thyroid hormone (T3 and T4) cellular uptake during a
single capillary passage through the isolated perfused rat
heart.
METHODS
Thyroid hormone uptake by the isolated rat heart was
investigated using the modified unidirectional paired tracer
dilution method and Langendorff´s technique for the isolated
heart with constant perfusion flow. The uptake of 125I-T3 and
125I-T4 from the extracellular space was determined relative to the
passage of a reference marker molecule 3H-mannitol.
Materials
The Krebs-Henseleit buffer contained (mM): NaCl 118, KCl 4.7,
NaHCO3 25, MgSO4.7H2O 1.7, CaCl2 2.5, KH2PO4 1.2 and
D-glucose 11 (Merck, Darmstadt, Germany). 
The scintillation fluid contained POPOP (0.05 g 1.4-bis(2-(5-
phenyloxazoly)) benzene) and PPO (6 g 2.5-diphenyloxazole)
per litre of toluene (Sigma Chemical Co., USA).
The specific radioactivities for 125I-triiodothyronine, 125I-thyroxine
and 3H-mannitol were 280–480, 200–310 and 955 mCi mM_1,
respectively. The radioisotopes 125I-triiodothyronine and 125I-
thyroxine were obtained from the Institute of Nuclear Science
‘Vinca’ (prepared using the chloramin-T-method; Hunter &
Greenwood, 1962), Belgrade, Yugoslavia, and 3H-mannitol was
purchased from Amersham International, UK. Unlabelled
triiodothyronine and thyroxine were obtained from Sigma
Chemical Co.
Methods
Isolation and perfusion of the rat heart. Wistar rats of both
sexes, weighing between 180 and 200 g, were killed by cervical
dislocation (according to Schedule 1 of the Animals, Scientific
procedures, Act 1986, UK), and the heart was excised and then
retrogradely perfused using Langendorff′s constant perfusion
flow technique, with a peristaltic pump at 3 ml min_1 (g wet heart
weight)_1. The perfusate was a modified Krebs-Henseleit buffer
equilibrated with 95 % O2–5 % CO2 and the pH was adjusted to
7.4 at 37 °C. Cardiac functions, heart rate and contractility, were
observed and registered using a PIC-Digital Recording System
(ECM, Kragujevac, Yugoslavia). The heart rate and
contractility were within physiologicals limits.
Measurement of 125I-thyroid hormone uptake. The thyroid
hormone uptake was measured using a rapid dual-isotope
dilution technique (Yudilevich & Mann, 1982). Following
20–30 min equilibration with Krebs-Henseleit buffer, a 100 µl
bolus was injected into the perfusion system containing 3H-
mannitol as an extracellular reference tracer, or 125I-thyroid
hormone (T3 or T4) as a test molecule. The first 30 drops and one
cumulative 4 min sample of venous effluent were sequentially
collected. This collection time was shown by preliminary
experiments to give more than 90 % recovery of reference tracer
(Rosic et al. 1987; Mitrovic et al. 1991). The samples were
prepared for scintillation counting (Rackbeta, LKB-Wallac
counter) by addition of 2 ml 98 % ethanol and 2 ml scintillation
fluid.
The purity of the iodinated components used, before (in the
perfusion medium) and after the experiments (in the effluent),
was higher than 98 % following sephadex G-25 chromatography
(Hunter & Greenwood, 1962 ). 
The radioactivity of each isotope in the venous effluent sample
(as a percentage of the injected dose) was plotted against the
collection time, in order to obtain venous concentration–time
curves, i.e. dilution profiles for both test and reference tracer.
The cellular uptake of 125I-thyroid hormone was estimated
directly from the venous dilution profiles using Eqn (1), where
125I-thyroid hormone (125I-TH) and 3H-mannitol (3H-man)
represent radioactivity (in counts min–1) recovered in successive
effluent samples:
Uptake (%) = (1 – 125I-TH/ 3H-man) X 100, (1)
The uptake is derived from the difference between the mannitol
value and that of thyroid hormone recovery in each drop. The
maximal uptake (Umax) of thyroid hormone is the mean of the
uptake values taken over the time period during which the
uptake has reached a plateau.
Unet is the mean uptake over the whole period, i.e. the recovered
activity in all drops. The net cellular uptake (Unet) was calculated
as:
Unet (%) = (1 – total recovered 125I/total recovered 3H) X 100,   (2)
The backflux (BF) of thyroid hormone from intracellular to
extracellular space could be calculated as:
BF (%) = ( Umax – Unet)/Umax, (3)
To determine the kinetics of the thyroid hormone uptake,
isolated hearts were perfused with different concentrations of the
unlabelled thyroid hormone. 
The inhibition of Umax in the presence of various concentration
of the unlabelled thyroid hormone was calculated as:
Inhibition (%) = [(Umax,control – Umax)/Umax,control ] X 100, (4)
The unidirectional transport or flux (V) of the thyroid hormone
from the extracellular space was estimated (in nM min_1) from
the maximal fractional tracer uptake (Umax), the perfusion rate
(F, ml min_1) and the concentration of unlabelled thyroid
hormone in perfusate (C, µM), as described by Yudilevich &
Mann (1982):
V = –F ln( 1 – Umax)C, (5)
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From the rate of thyroid hormone uptake, in the presence of
different concentrations of unlabelled thyroid hormone, the
Michaelis-Menten constant (Km) and Vmax (the maximal rate of
125I-thyroid hormone transport from the extracellular space to
heart cells) were calculated using Eadie-Hoffstee analysis
(Hoffstee, 1959).
Statistics
The data were analysed using Student′s t test; a P value of < 0.05
was considered as statistically significant.
RESULTS
In the first group of experimental animals we investigated
the dynamics and kinetics of 125I-T4 transport from the
extracellular space into the heart cells, during a single
capillary 125I-T4 passage through the coronary circulation.
Dilution profiles for 3H-mannitol and 125I-T4 (obtained
from the coronary sinus effluent after the bolus injection
of tracers into the aorta) are illustrated in Fig. 1. H3 and
I125 radioactivities, expressed as a percentage of the total
injected dose, in each drop of venous effluent (labelled %
Recovered dose) were plotted against the collection time.
The dilution profile curve for 125I-T4 shows lower values
than the dilution profile curve for 3H-mannitol, which
demonstrates 125I-T4 uptake by the heart cells.
Figure 2 illustrates the uptake plot obtained using the
equation for uptake (Eqn (1)), as explained in Methods.
The maximal cellular uptake (Umax) was determined from
the maximal values in this plot, and it appears 38–66 s
after the bolus was given.
The dynamics of 125I-T4 transport from the extracellular space
into heart cells, during a single capillary passage through the
coronary circulation, is summarized in Table 1, which
includes calculated values of Umax, Unet and backflux (BF) of
125I-T4 from the intracellular space. The control Umax value for
125I-T4 was 54.4 ± 0.58 %, and Unet was 25.69 ± 3.50 %. The
backflux of 125I-T4 from the intracellular space was
53.17 ± 8.50 %.
To determine the kinetics of 125I-T4 transport from the
extracellular space into heart cells, various concentrations of
unlabelled T4 were added in the perfusion medium. At the
lowest concentration used, 1 µM, Umax was 48.9 ± 1.04 %
(Table 2.). For the other concentrations used, from 10 µM to
275 µM, the maximal uptake values were from 40.8 ± 1.44 %
to 21.9 ± 2.90 %. These results show that maximal cellular
uptake of 125I-T4 was reduced from 10.1 ± 2.9 % to
59.74 ± 8.85 %, depending on the concentration of unlabelled
hormone (T4) (Table 2)
The rate of unidirectional 125I-T4 transport or flux in the
presence of increasing concentrations of unlabelled T4 was
estimated using Eqn 4 (Methods) and is shown in Fig. 3.
The Michaelis-Menten constant (Km) and Vmax were then
estimated as previously described in Methods. The Km was
105.46 ± 15.69 µM and Vmax was 177.84 ± 11.50 nmol min–1.
The dynamics and kinetics of 125I-T3 transport from the extra-
cellular space into the heart cells, during a single capillary T3
passage through the coronary circulation, were investigated in
the second group of experimental animals.
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Figure 1
The recovery of 3H-mannitol and 125I-thyroxine as a
percentage of injected radioactivity plotted against
collection time (s). The lower recovery of
125I-thyroxine relative to 3H-mannitol indicates
thyroxine uptake by the heart cells.
Figure 2
Uptake of 125I-thyroxine relative to 3H-mannitol
plotted against collection time (s).
Table 1. Dynamics of 125I-triiodothyronine and 125I-thyroxine
transport from the extracellular space into the heart cells
Umax (%)* Unet (%)* BF (%)* n
125I-thyrox. 54.4 ± 0.58 25.69 ± 3.50 53.17 ± 8.50 7 
125I-triiodo. 52.15 ± 0.76 25.49 ± 10.6 61.59 ± 14.26 5 
*Student’s t test; P < 0.05. Values are means ± S.E.M;
n, number of experiments.
Figure 4 illustrates dilution profiles for 3H-mannitol and
125I-T3. H3 and I125 radioactivities, expressed as a percentage of
the total injected dose, in each drop of venous effluent were
plotted against the collection time. The dilution profile curve
for 125I-T3 shows lower values than the dilution profile curve
for 3H-mannitol, which demonstrates 125I-T3 uptake by the
heart cells.
The uptake plot for 125I-T3 is shown in Fig. 5. Maximal
cellular 125I-T3 uptake (Umax) was determined from the
maximal values in this plot, and it appears 13.7–35.45 s after
the bolus injection.
The basic nature of T3 transport during a single passage
through the coronary circulation is summarized in Table 1,
which includes calculated values of Umax, Unet and backflux
(BF) of T3 from the intracellular space.
The kinetics of T3 transport from the extracellular space into
heart cells was measured with various concentrations of
unlabelled T3 present in the perfusion medium. At the lowest
concentration used, 34.9 µM, Umax was 34.1 ± 5.6 % (Table 3).
These results show that maximal cellular uptake of 125I-T3 was
reduced (see Table 3) depending on the concentration of the
unlabelled T3 hormone.
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Table 2. Maximal 125I-thyroxine uptake by heart cells in the
presence of various concentrations of unlabelled thyroxine
Unlabelled T4 (µM) Umax (%)* Inhibition (%)*
Control 54.40 ± 0.58 —
1 48.9 ± 1.04 10.1 ± 2.9 
10 40.8 ± 1.44 24.98 ± 6.3
34.37 45.64 ± 3.04 16.09 ± 5.6
70 39.43 ± 2.78 27.53 ± 5.1
137.5 39.24 ± 1.18 27.87 ± 5.2
206 28.15 ± 2.1 48.25 ± 6.4
275 21.9 ± 2.90 59.74 ± 8.85
* Student’s t test; P < 0.05. Values are mean ± S.E.M.
Figure 3
The rate of unidirectional 125I-thyroxine transport or
flux (V).
Figure 4
The recovery of 3H-mannitol and 125I-triiodo-
thyronine as a percentage of injected radioactivity
plotted against collection time (s). The lower
recovery of 125I-triiodothyronine relative to
3H-mannitol indicates triiodothyronine uptake by
the heart cells.
Figure 5
Uptake of 125I-triiodothyronine relative to
3H-mannitol plotted against collection time (s). 
Table 3. Maximal 125I-triiodothyronine uptake by heart cells in the
presence of various concentrations of unlabelled triiodothyronine
Unlabelled T4 (µM) Umax (%)* Inhibition (%)*
Control 52.15 ± 0.76 —
35 34.1 ± 5.6 34.61 ± 10.7
70 25.54 ± 4.4 51.04 ± 8.46
140 28.95 ± 8.65 44.49 ± 16.58
211 23.75 ± 6.4 54.45 ± 9.15
282 18.1 ± 4.88 65.26 ± 9.37
* Student’s t test; P < 0.05. Values are mean ± S.E.M.
The rate of unidirectional 125I-T3 transport or flux in the
presence of increasing concentrations of the unlabelled T3 was
estimated using the Eqn (4) (Methods) and shown in Fig. 6.
The Michaelis-Menten constant (Km) was 80.0 ± 14.04 µM
and Vmax was 118.5 ± 22.57 nM min_1.
DISCUSSION
To examine the dynamics and kinetics of 125I-thyroxine and
125I-triiodothyronine transport from the extracellular space
into heart cells, the modified unidirectional paired tracer
dilution method (Rosic et al. 1996) and Langendorff′s
technique for the isolated heart with constant perfusion flow
were used. In these experiments T4 and T3 uptake by the cells
of intact hearts were measured. 125I-T4 and 125I-T3 uptake by
the heart cells was measured relative to 3H-mannitol, as a
reference tracer. Mannitol is a marker molecule and its
recovery in coronary venous effluent represents a simple
diffusion into and out of the extracellular space (Mann &
Yudilevich, 1984; Samuels, 1988; Preston & Segal, 1992a,b;
Kostic et al. 1995), whereas the lower values of thyroxine
(Fig. 1) and triiodothyronine (Fig. 4) recovery reflect cellular
uptake.
Our results show that the maximal values of the recovered
radioactivity of the thyroid hormones (125I-T3 and 125I-T4)
and the reference tracer (3H-mannitol) appeared in the
same fraction of coronary venous effluent (Figs 1 and 4).
The evident parallelism of the curves, obtained in our
experiments and the coincident peak of recovered
radioactivity indicate that both the test (125I-T3 and 125I-T4)
and the reference (3H-mannitol) molecules have similar
diffusion characteristics. The reliable and reproductive
results gained with this method confirms its application,
although it gives us no information as to where the
hormone was bound in the cell.
The positive values of 125I-thyroid hormone uptake appeared
16 s (T4) and 8 s (T3) after the moment of tracer injection into
the coronary circulation, and these values were positive within
92 s (for 125I-T4) and within 60 s (for 125I-T3) of collection time
(Figs 2 and 5).
Maximal values for thyroid hormone uptake, relative to
3H-mannitol, appeared between 38 and 55 s for 125I-T4 and
between 14 and 35 s for 125I-T3 after the start of sample
collection, and they were, respectively, 54.4 ± 0.58 % and
52.15 ± 0.76 % (Table 1.). These mean values for maximal
thyroid hormone (125I-T4 and 125I-T3) uptake reflect the
relatively high 125I-T4 and 125I-T3 uptake by the rat heart cells,
which is in accordance with values obtained from the isolated
perfused sheep choroid plexus (Preston & Segal, 1992a).
Furthermore, our results for inhibition of maximal thyroid
hormone (125I-T4 and 125I-T3) uptake in the presence of
unlabelled thyroid hormones suggest a saturable mechanism
for T4 and T3 uptake by cells in the isolated rat heart, with a
higher uptake capacity (Vmax) for T4 than for T3 carriers. The
Km values show no significant difference, suggesting similar
affinities of T4 and T3 for their respective carriers. 
Our results provide relevant and useful information for
further investigations which will evaluate whether
hyperthyroidism and/or hypothyroidism can affect the
membrane uptake of thyroid hormones under experimental
conditions.
Conclusions
The results of this study have shown that the modified
unidirectional paired tracer dilution method and
Langendorff′s technique for the isolated heart with
constant perfusion flow gave reliable and reproducible
results, which support its application in the study of the
dynamics and kinetics of thyroid hormone transport from
the extracellular space into heart cells.
The results showing inhibition of maximal 125I-T3 and 125I-T4
uptake in the presence of the unlabelled T3 and T4 indicate
that specific carrier transport mechanism(s) for thyroid
hormones, with relatively high Vmax and low Km values, exist
in the heart cells.
Thyroxine carriers in heart cells showed a higher binding
capacity (Vmax) than triiodothyronine carriers, but the carriers
showed a similar affinity for thyroxine and triiodothyronine.
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